microRNA 5194 (miR-5194)

microRNA 5194 (miR-5194), also referred to as hsa-mir-5194 or MIR5194, is a member of the microRNA family—small, non-coding RNAs that regulate gene expression post-transcriptionally, primarily by binding to complementary sequences in messenger RNAs (mRNAs) and inhibiting their translation or facilitating their degradation[1][2][5]. According to the GSEA Molecular Signature Database, miR-5194 is catalogued as a regulatory microRNA with predicted high-confidence gene targets based on sequence analysis, but there is no direct evidence in the current literature indicating it serves as a well-characterized therapeutic target, nor is it clearly associated with major disease processes[4]. There are no known drugs, clinical biomarkers, or safety concerns specifically associated with this molecule. There is limited information on miR-5194 compared to well-studied microRNAs; it is not featured in major reviews of microRNAs in health and disease, and no data were found that would classify it as a current pharmacological or clinical target. Thus, "miR-5194" is a biochemically valid microRNA, but is not recognized as a defined therapeutic target or candidate biomarker at this time[4]. Note: - "Is_target" is set to false because there is no evidence this is currently a druggable target (such as a receptor, enzyme, or protein with established roles in therapy or diagnostics). - "Is_incorrect" is set to true to flag that the entity is not a classical or established therapeutic target, and such microRNAs (without specific functional or clinical annotation) are commonly included in bioinformatic microRNA databases but lack direct biological or clinical characterization in the literature.

Other names

hsa-mir-5194MIR5194mir-5194